Anavex Life Sciences (AVXL) Tops Q3 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q3 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Cargojet Inc. (CJT:CN) (CGGJF) PT Raised to $128 at TD Cowen, maintains bullish call
• Trio-Tech wins $4.7M automotive semiconductor burn-in contract